Hereditary Angioedema Kininogen Assay

clinical trial

Details

Instance of: clinical trial
Start time: 1 September 2019
End time: 1 September 2020
Country: Germany
Main subject: angioedema
minimum age: 18
number of participants: 100
research intervention: bradykinin triacetate
study type: observational study
title: Hereditary Angioedema Kininogen Assay. A Multicenter Epidemiological Observational Study.

Nothing in the MetaHistoryBook collection references this item yet.